Hayat Pharmaceutical Industries Co. PLC

HPIC

JO4121011012

Pharmaceuticals

End-of-day quote Amman S.E. Other stock markets 06:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
2.53 ^JOD	-0.78%		-0.78%	+5.42%

Apr. 29	Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 31	Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hayat Pharmaceutical Industries : Trading (HPIC) 2024 04 21

April 21, 2024 at 05:16 am EDT

HAYAT PHARMACEUTICAL INDUSTRIES CO.

To: Jordan Securities Commission,

ﺔﻴﻟﺎﻤﻟﺍ ﻕﺍﺭﻭﻻﺍ ﺔﺌﻴﻫ ﺓﺩﺎﺴﻟﺍ

Amman Stock Exchange

ﻥﺎﻤﻋ ﺔﺻﺭﻮﺑ ﺓﺩﺎﺴﻟﺍ

Company's Name: HAYAT PHARMACEUTICAL

ﺔﻴﺋﺍﻭﺪﻟﺍ ﺕﺎﻋﺎﻨﺼﻠﻟ ﺓﺎﻴﺤﻟﺍ :ﺔﻛﺮﺸﻟﺍ ﻢﺳﺍ

INDUSTRIES CO.

AM 11:58:55 2024-04-21 :ﺦﻳﺭﺎﺘﻟﺍ

Date: 21-04-2024 11:58:55 AM

ﺔﻴﻟﺎﻤﻟﺍ ﻕﺍﺭﻭﻷﺎﺑ ﻝﻭﺍﺪﺗ :ﻉﻮﺿﻮﻤﻟﺍ

Subject: Trading in securities

Kindly be informed that Adnan Mohammad Ibrahim

ﺦﻳﺭﺎﺘﺑ ﻡﺎﻗ ﺪﻗ ﺭﻭﺮﺤﺷ ﻢﻴﻫﺍﺮﺑﺍ ﺪﻤﺤﻣ ﻥﺎﻧﺪﻋ ﻥﺄﺑ ﻢﻜﻣﻼﻋﺇ ﻮﺟﺭﺃ

Shahrour purchased/sold on the 18-04-2024 shares from

ﺕﺎﻋﺎﻨﺼﻠﻟ ﺓﺎﻴﺤﻟﺍ ﻲﻓ ﻢﻬﺳﺍ ﻊﻴﺑ /ﺀﺍﺮﺸﺑ 2024-04-18

company HAYAT PHARMACEUTICAL INDUSTRIES

.ﻩﺎﻧﺩﺍ ﺢﺿﻮﻣ ﻮﻫ ﺎﻤﻛﻭ (10142)ﺔﻴﺋﺍﻭﺪﻟﺍ

CO.(10142).

Following are the details as below.

Type of

Number

Total

Percentag

ﺔﺒﺴﻧ

ﺩﺪﻌﻟﺍ

ﺩﺪﻋ

ﻉﻮﻧ

transactio

Of Share

number of

e of

ﺔﻴﻜﻠﻤﻟﺍ

ﻲﻟﺎﻤﺟﻹﺍ

ﻢﻬﺳﻻﺍ

ﺔﻠﻣﺎﻌﻤﻟﺍ

Transacte

ownershi

ﺪﻌﺑ

ﻢﻬﺳﻸﻟ

ﺔﻟﻭﺍﺪﺘﻤﻟﺍ

held

p after

ﺔﻠﻣﺎﻌﻤﻟﺍ

ﻆﻔﺘﺤﻤﻟﺍ

transactio

ﺎﻬﺑ

2822

ﻊﻴﺑ

Sale

2822

Relation to the company

ﺔﻛﺮﺸﻟﺍ ﻊﻣ ﺔﻗﻼﻌﻟﺍ

Other

ﻯﺮﺧﺃ

Brother of Chairman Omar Mohd Ibrahim Shahrour

ﺭﻭﺮﺤﺷ ﻢﻴﻫﺍﺮﺑﺍ ﺪﻤﺤﻣ ﺮﻤﻋ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺲﻴﺋﺭ ﻖﻴﻘﺷ

Please accept our sincere thanks and appreciation.

.ﻡﺍﺮﺘﺣﻻﺍ ﻖﺋﺎﻓ ﻝﻮﺒﻘﺑ ﺍﻮﻠﻀﻔﺗﻭ

Name: ﺔﻨﻳﺪﻟﺍ ﺮﻴﺒﻋ

ﺔﻨﻳﺪﻟﺍ ﺮﻴﺒﻋ :ﻢﺳﻻﺍ

Position:

Secretaro of the board of director

ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺮﺳ ﻦﻴﻣﺍﺍ

:ﺐﺼﻨﻤﻟﺍ

Page 1 of 1

Attachments

Original Link
Original Document
Permalink

Disclaimer

Hayat Pharmaceutical Industries Co. PSC published this content on 21 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 April 2024 09:15:06 UTC.

Latest news about Hayat Pharmaceutical Industries Co. PLC

Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 31	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-29	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-11	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-28	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-24	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-30	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-04	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-27	CI
Hayat Pharmaceutical Industries Co. plc Announces Earnings Results for the Second Quarter Ended June 30, 2020	20-07-27	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-07	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-07-30	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the First Quarter Ended March 31, 2019	19-04-30	CI
Hayat Pharmaceutical Industries Co. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-27	CI
Hayat Pharmaceutical Industries Appoints Zia Mahmoud Mousa as Chief Financial Officer	17-05-30	CI

Chart Hayat Pharmaceutical Industries Co. PLC

Duration

Period

Chart Hayat Pharmaceutical Industries Co. PLC

More charts

Company Profile

Hayat Pharmaceutical Industries Company PSC is a Jordan-based company engaged in the pharmaceutical sector. The Company specializes in the manufacture of different forms of human pharmaceuticals, veterinary medicines, medical plasters, medical gauze and medical braces, in addition to the production of skin care and beauty supplies and surgical suture. The Companyâs manufacturing facility is spread over an approximately 8,000 square meter area on the outskirts of the capital city Amman. The Companyâs production areas are divided into the following: Solid production area, which covers tablets, capsules, dry suspension, suppositories, syrups and solutions, cream and ointments, and Semi-solid and Liquid production area, which includes creams, ointments, gels and emulsions, suppositories line, syrups line and shampoo line. The Companyâs products include Anti-microbials, Gynecological, Dermatological, Gastrointestinal, Antihypertensives and Vasoactive, Neurological, and Respiratory products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HAYAT PHARMACEUTICAL INDUSTRIES CO. PLC	+5.42%	33.91M
ELI LILLY AND COMPANY	+26.57%	681B
NOVO NORDISK A/S	+21.85%	556B
JOHNSON & JOHNSON	-5.11%	361B
MERCK & CO., INC.	+17.24%	325B
ABBVIE INC.	+5.16%	285B
ASTRAZENECA PLC	+13.68%	235B
NOVARTIS AG	+3.65%	199B
ROCHE HOLDING AG	-11.12%	189B
PFIZER, INC.	-4.10%	157B